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We hypothesised that probiotic supplementation (PRO) increases the absorption and  oxidation of 47 
orally ingested maltodextrin during 2h endurance cycling, thereby sparing muscle glycogen for a 48 
subsequent time trial (simulating a road race). Measurements were made of lipid and carbohydrate 49 
oxidation, plasma metabolites and insulin, gastrointestinal permeability, and subjective symptoms of 50 
discomfort. Seven male cyclists were randomized to PRO (bacterial composition given in methods) or 51 
placebo (PLC) for four weeks, separated by a 14-day washout period. After each period, cyclists 52 
consumed a 10% maltodextrin solution (initial 8 mL·kg-1 bolus and 2 mL·kg-1 every 15 min) while 53 
exercising for 2h at 55% Wmax followed by a 100 kJ time trial. PRO resulted in small increases in peak 54 
oxidation rates of the ingested maltodextrin (0.84 ± 0.10 vs 0.77 ± 0.09 g·min-1, P = 0.016), and mean 55 
total carbohydrate oxidation (2.20 ± 0.25 vs 1.87 ± 0.39 g·min-1, P = 0.038), while fat oxidation was 56 
reduced (0.40 ± 0.11 vs 0.55 ± 0.10 g·min-1, P = 0.021) . During PRO small but significant increases were 57 
seen in glucose absorption, plasma glucose and insulin concentration and decreases in NEFA and 58 
glycerol. Differences between markers of GI damage and permeability and time trial performance 59 
were not significant (P > 0.05). In contrast to the hypothesis, PRO led to minimal increases in 60 
absorption and oxidation of the ingested maltodextrin and small reductions in fat oxidation, while 61 
having no effect on subsequent time trial performance. 62 






Adequate CHO availability, as the main fuel for skeletal muscle and the central nervous system during 65 
endurance exercise lasting 1-2 h, and the maintenance of high CHO oxidation rates is a critical 66 
component for optimal performance. Liver and muscle glycogen stores are limited and oral ingestion 67 
of CHO before and during exercise has been reported to improve performance (11) and delay fatigue 68 
during cycling and running (9, 51). This performance benefit has since been reported in numerous 69 
publications, with exogenous carbohydrate ingestion showing ergogenic effects for endurance 70 
performance in most of these studies (39, 49). However, oxidation rates of orally ingested glucose and 71 
maltodextrin (glucose polymer) solutions appear to plateau around 1 g.min-1 (or 60 g·h-1) (53), even 72 
with ingestion rates as high as 2.6 g.min-1  (26). A finding that has been shown many times (12). The 73 
capacity of the sodium-glucose transporter (SGLT1) in the small intestine is generally regarded as the 74 
limiting factor for glucose absorption and the oxidation rate of glucose and maltodextrin ingested 75 
during endurance exercise (21). While there appears to be a mean maximal rate of exogenous glucose 76 
oxidation of 1 g·min-1 there appears to be variation between individuals in one study (53) and also 77 
between studies (23). Environmental factors can also reduce the maximal oxidation of consumed 78 
carbohydrates. Reductions in exogenous carbohydrate oxidation have been seen at increased 79 
environmental temperatures (20). This has been related to reductions in splanchnic blood flow and 80 
compromised intestinal absorption (47). Strategies that may increase the maximal oxidation rate of 81 
orally ingested carbohydrates either above the previously established 1 g·min-1, or above an 82 
individual’s own maximal oxidation rate under normal or compromised environmental conditions 83 
could be of benefit to endurance athletes.    84 
One such method proposed to increase the oxidation of ingested CHO during exercise is 85 
supplementation with probiotic bacteria. In vitro research has shown that co-incubation of Caco-2 86 
cells (enterocyte model) with as yet unidentified, heat labile metabolites from bacterial strains from 87 
the Lactobacilli species increases glucose uptake (46). Probiotics can also modulate luminal short chain 88 
fatty acid production (44) which are shown to increase both the abundance and activity of SGLT1 (50) 89 
as well as increasing insulin secretion following CHO ingestion (28). The latter of these could have 90 
wider implications on total CHO oxidation given that insulin suppresses lipolysis and lipid oxidation 91 
during exercise (19). There are then potential mechanisms by which probiotics could increase 92 
absorption and so the subsequent oxidation of consumed glucose, as well as altering total 93 
carbohydrate oxidation, and these findings could have practical and relevant implications for athletes 94 
if replicable during endurance exercise.  95 
As well as the potential to increase CHO absorption and oxidation, probiotics have also been proposed 96 





that probiotic supplementation, or inoculation with the metabolites of probiotic bacteria, can prevent 98 
epithelial apoptosis (57), increase mucin secretion (6), inhibit attachment of pathogenic bacteria (3), 99 
as well as increase expression of tight junction proteins and decrease secretion of pro-inflammatory 100 
cytokines (33). Given that endurance exercise has been shown to increase markers of GI permeability 101 
(e.g. serum lactulose:rhamnose ratio; LR) and damage (e.g. intestinal-fatty acid binding protein; I-102 
FABP) (52), probiotic supplementation could attenuate such changes in GI physiology. While there is 103 
some evidence that probiotic supplementation can attenuate exercise induced increases in GI 104 
permeability and circulatory endotoxin concentrations (45), we have previously shown there to be no 105 
effect (43). However, it is difficult to draw definitive conclusions from such field based studies. 106 
Laboratory controlled investigations should hopefully provide more insight into the effects of 107 
probiotics on exercise-induced GI damage. 108 
The aim of the current study was to investigate whether probiotic supplementation increases the 109 
oxidation of an ingested maltodextrin drink and total CHO oxidation during 2 h of cycling exercise at 110 
55% Wmax. It is hypothesised that 4 weeks of probiotic supplementation would increase the intestinal 111 
digestion and absorption rate of the maltodextrin drink, the percent contribution of the drink to 112 
carbohydrate oxidation rates and total carbohydrate oxidation rates. It is also hypothesised that the 113 
ingestion of the probiotic supplement would significantly reduce the LR ratio and intestinal damage 114 
(I-FABP) and improve performance during the 2 h of cycling exercise. These hypotheses have been 115 




Seven trained cyclists participated in this study (mean ± SD; age 23 ± 4 yrs, body mass 73.4 ± 7.1 kg, 120 
V̇O2peak 64.0 ± 2.2 mL·kg-1·min-1). None of the participants used medication (e.g. NSAIDs, 121 
antidepressants, or diuretics) or nutritional supplements or reported a history of GI-related medical 122 
issues (e.g. irritable bowel disease or abdominal surgery). After explaining the nature and risks of the 123 
experimental procedures to the subjects, their informed written consent was obtained. The study was 124 
approved by the institutional ethics committee of Liverpool John Moores University and conformed 125 
to the standards set by the Declaration of Helsinki. 126 
Pre-testing 127 
At least 7 days prior to the first experimental trial, subjects completed preliminary testing. V̇O2peak and 128 
maximal aerobic power output (Wmax) were determined on an electronically braked cycle ergometer 129 





Work rate commenced at 95 W for 3 min, followed by incremental steps of 35 W every 3 min until 131 
volitional exhaustion. Oxygen uptake was measured continuously during exercise using an on-line gas 132 
analysis system (Moxus modular metabolic system, AEI technologies Inc, Pennsylvania, USA). V̇O2peak 133 
was determined from highest recorded V̇O2 value from 10 s averages. Wmax was calculated from the 134 
last completed work rate, plus the fraction of time spent in the final non-completed work rate 135 
multiplied by the work rate increment (22). After a rest period of 30-60 minutes, participants then 136 
completed 1 h of cycling exercise at 55% Wmax following the prescribed drinking protocol and followed 137 
by a time trial to familiarise themselves to the real testing procedures described in the following  138 
paragraphs. 139 
Treatment allocation 140 
In a randomized, double-blind, placebo-controlled crossover design, each subject completed two 28 141 
day periods of supplementation as well as consuming an additional supplement capsule on the 142 
morning of the trials at the end of each intervention period, one hour before commencing exercise. 143 
This 28 day supplement period is in line with our previous work showing lower GI symptoms during 144 
exercise (43). Each supplement period was separated by a 14 day washout period. This wash out 145 
period was based upon unpublished data showing the probiotic strains used are undetectable from 146 
stool samples after this time. It also has been shown that this period allows for a number of complete 147 
epithelial cell turnovers within the small intestine (2). Participants were randomized to consume either 148 
a capsule of a commercially available probiotic (PRO) or a visually identical placebo daily for 28 days. 149 
The PRO supplement contained the active strains Lactobacillus acidophilus (CUL60), Lactobacillus 150 
acidophilus (CUL21), Bifidobacterium bifidum (CUL20) and Bifidobacterium animalis subsp. lactis 151 
(CUL34) (Proven Probiotics, Port Talbot, UK). The minimum concentration was 25 billion colony-152 
forming units (CFU). This probiotic supplement has previously been shown to survive the GI tract 153 
during consumption (31) and have beneficial effects for endurance athletes (43, 45). During the 154 
supplementation period, participants were informed to avoid consumption of probiotic foods such as 155 
fermented foods and yogurts. The PLC capsules were visually identical and consisted of starch only 156 
(Proven Probiotics, Port Talbot, UK). Subjects were instructed to swallow the capsule daily after their 157 
first meal. The randomization code was held by a third party (Cultech Ltd) and unlocked for statistical 158 
analyses by the authors upon sample analysis completion.  159 
Experimental trials 160 
Each subject underwent four experimental trials; one prior to and at the end of each supplementation 161 
period. Trials consisted of 120 min of cycling at 55% Wmax, in line with previous work examining 162 
exogenous oxidation during cycling exercise (55, 58). This was followed by a time trial amounting to 163 





instructed not to perform any strenuous exercise 24 hr prior to testing and to avoid caffeine, alcohol, 165 
and any spicy food. Subjects also recorded their food intake in the 24 hr before the first trial and 166 
repeated this for each subsequent visit.  167 
Subjects reported to the laboratory at the same time (~7:30am) for each trial after an overnight fast 168 
of at least 12 hours. A cannula (Safety Lock 22G, BD Biosciences, West Sussex UK) was inserted into 169 
the antecubital vein and baseline blood sample was taken. Resting breath samples were collected over 170 
a 5 min period (Moxus modular metabolic system, AEI technologies Inc, Pennsylvania, USA) and 171 
exetainer tubes were filled directly from the mixing chamber to determine the 13C/12C ratio in expired 172 
CO2. Subjects then began cycling at 55% Wmax for 120 minutes. Heart rate (Polar FT1 HRM, Polar 173 
Electro, Kempele, Finland) and ratings of perceived exertion (RPE) (4) were recorded every 15 minutes. 174 
Immediately following the 120 minutes of steady state cycling, simulated cycling time trials were 175 
undertaken with the ergometer set in a cadence-dependent power output (linear) mode for subjects 176 
to complete 100kJ of work. Power output was therefore a function of cadence and a fixed factor (alpha 177 
value) was used, as described in the following equation: Power (W) = L × rpm2, in which the rpm is the 178 
pedalling rate, and L is a linear factor. This factor was chosen in a way that would evoke 100% peak 179 
aerobic power output at a pedalling rate of 90 rpm. 180 
Maltodextrin drink 181 
During exercise subjects consumed a 10% CHO drink enriched with the stable isotope [U-13C]glucose 182 
(CK Isotopes, Ibstock, UK). 176.4 g maltodextrin (Myprotein®Inc, Northwich, UK) and 3.6 g [U-183 
13C]glucose were dissolved in water and made up to a total volume of 1800ml. For the two participants 184 
in which the oxidation rate of the ingested maltodextrin was not measured, the drink consisted of 10% 185 
maltodextrin only. Total drink volume was prescribed according to participant weight with an 8 mL·kg-186 
1bw bolus in the first 3 minutes of exercise followed by 2 mL·kg-1bw each subsequent 15 min during 187 
120 min cycling exercise (24). Total fluid volume and carbohydrate intakes prescribed were 1790 ± 188 
152 mL and 179 ± 15.2 g respectively. An elemental analyser isotope ratio mass spectrometer (EA-189 
IRMS; Europa Scientific 20–20, Iso-Analytical Ltd, Crewe, UK) was used to accurately measure the 13C-190 
enrichment of freeze-dried samples of the maltodextrin/[U-13C]glucose drinks and the natural 13C-191 
background enrichment of the maltodextrin powder expressed as δ13C ‰ vs PDB. The 13C-enrichment 192 
of the consumed drinks was very high at 1681 ‰ vs PDB.  The drinks also contained 35 mmol·L−1 of 193 
sodium chloride as sodium in the 30-50mmol.L-1 range leads to better fluid delivery and retention in 194 





13C/12C analysis of breath CO2 196 
Breath samples were analysed using an isotope ratio mass spectrometer (Delta XP, coupled to a Gas 197 
Bench II and GC Pal autosampler (ThermoElectron, Bremen, Germany).  The breath tubes were held 198 
in a heated sample tray at 26oC. The breath sample was continuously transferred through a Valco 199 
sampling port in a flow of helium.  Carbon dioxide was separated from the presence of other gases by 200 
using a capillary column (PoraPLOTQ; Agilent JW columns) with dimensions of 27.5 m x 0.32 mm x 10 201 
µm. The oven temperature was kept constant at 68 °C. Nafion water traps removed H2O from the 202 
sample.  Multiple analysis of each sample was achieved by switching the contents of the sample loop 203 
to the GC column every 50 seconds. Each switch corresponded to starting the GC separation of the 204 
sample coming from the loop.  Ions m/z 44 and 45 were monitored for CO2 and 13CO2 respectively. The 205 
13C enrichment results from breath samples were expressed as δ13C ‰ vs PDB. The δ13C ‰ vs PDB 206 
results of the maltodextrin powder, the maltodextrin/[U-13C]glucose drinks and breath samples  were 207 
converted to the tracer-to-tracee ratio (TTR) by using the following equation: 208 
TTR (13C:12C) = [(δ13C‰/1000) + 1] × 0.0112372 (14) 209 
Analysis of plasma [U-13C]glucose enrichment 210 
Plasma glucose isotope enrichment was measured as the tracer/tracee ratio (TTR) by gas-211 
chromatography mass spectrometry using a trimethyl silyl-O-methyloxime derivative according to 212 
methods previously described (48).  The peak areas of the ions m/z 319.2 and m/z 323.2, for natural 213 
glucose and [U-13C]glucose respectively, were measured by GC-MS on a Agilents 5975C Inert XL EC/CI 214 
MSD (Agilent Technologies, Wokingham, Berks, UK).  215 
The concentration of [U-13C]glucose in the plasma ([U-13C]Glup) was calculated as follows: 216 
[U-13C]Glup = Glup × TTR 217 
 where Glup is the plasma glucose concentration in mmol.L-1  and TTR of [U-13C]glucose in the plasma. 218 
At any given time point, the concentration of unlabelled glucose ([12C]Glup mmol.L-1) in the plasma 219 
that had originated from the maltodextrin drink was derived from the known enrichment of the 220 
glucose in the drink as follows: 221 
[12C]Glup = ([U-13C]Glup / 3.1) ×  (100 – 3.1) 222 
where 3.1 is the % isotopic enrichment of the test drink. 223 
The total concentration of glucose in plasma that originated from the maltodextrin drink (Glum) was 224 





Glum = [12C]Glup + [U-13C]Glup 226 
and the difference between this value and total plasma glucose concentration was assumed to have 227 
been derived endogenously. This calculation distinguishes between [12C]Glu produced endogenously 228 
and [12C]Glu in the test drink. 229 
Indirect calorimetry and calculations 230 
Respiratory gas exchange variables were measured using a mixing chamber (Moxus modular 231 
metabolic system, AEI technologies Inc, Pennsylvania, USA) with oxygen uptake (V̇O2), carbon dioxide 232 
output (V̇CO2), and respiratory exchange ratio (RER) measured  during a 4 min interval and sample 233 
frequency of 15 seconds after every  15 min during the 2 h of cycling exercise. Breath samples were 234 
collected in duplicate directly from the mixing chamber of the MOXUS system into sealed vacutainer 235 
collection tubes again every 15 min. Total CHO and fat oxidation rates were calculated from indirect 236 
calorimetry data assuming negligible protein oxidation (27): 237 
Glucose oxidation = 4.55 × V̇CO2 − 3.21 × V̇O2 238 
Fat oxidation = 1.67 × V̇O2 − 1.67 × V̇CO2 239 
Exogenous glucose oxidation was calculated using the formula (35): 240 
= V̇CO2 × (δExp − δExpbkg)/(δIng − δExpbkg)/k 241 
in which δExp is the 13C enrichment of expired air during exercise at different time points, δIng is the 242 
[U-13C]enrichment of the ingested maltodextrin drink, δExpbkg is the 13C enrichment of expired air 243 
before exercise (background), and k is the amount of CO2 (in litres (L)) produced by the oxidation of 1 244 
g of glucose (k = 0.7467 L CO2/g glucose).  245 
Plasma glucose oxidation was calculated using the formula: 246 
= V̇CO2 × (δExp – δExpbkgδ/δPG − δPGbkg)/k 247 
in which, δPG is the plasma [U-13C]glucose enrichment during exercise and δPGbkg is the plasma [U-248 
13C]glucose enrichment before ingestion of the maltodextrin/[U-13C]glucose drink and the start of 249 
exercise (background sample). In the above calculations, the 13C-enrichments were all expressed as 250 
tracer to tracee ratio (TTR) for all analysed samples (breath, enriched maltodextrin drinks, unenriched 251 
maltodextrin powder, plasma glucose).  252 
Because plasma glucose oxidation represents the oxidation of both glucose coming from the gut 253 





derived glucose oxidation and muscle glycogen oxidation could be calculated by the following 255 
formulas: 256 
Liver­derived glucose oxidation = plasma glucose oxidation − exogenous glucose oxidation 257 
Muscle glycogen oxidation = total CHO oxidation − plasma glucose oxidation 258 
Blood parameter analysis 259 
Plasma glucose, lactate, non-esterified fatty acids, and glycerol were analysed using a Randox Daytona 260 
spectrophotometer and commercially available kits (Randox Laboratories, Ireland). Analysis for 261 
lactulose and rhamnose ratio (LR) as a marker of GI permeability and intestinal fatty acid binding 262 
protein (I-FABP) were performed as previously described (42). Cytokine concentrations were 263 
measured using cytometric bead array (CBA, BD Biosciences, San Diego, USA) for the cytokines IL-1α 264 
IL-6, IL-8, and IL-10 using the manufacturer's instructions with four bead populations with distinct 265 
fluorescence intensities coated with capture antibodies specific for IL-1α IL-6, IL-8, and IL-10 proteins. 266 
Following acquisition of sample data using the flow cytometer, the sample results were generated in 267 
graphical and tabular format using the BD CBA Analysis Software. Post exercise and 1hr post exercise 268 
sample concentrations were corrected for plasma volume changes as described by Dill and Costill (13). 269 
Assessment of gastrointestinal damage and symptoms 270 
Intestinal permeability was assessed by analysing serum samples using a previously published protocol 271 
(15), with the modification of using rhamnose instead of mannitol as the monosaccharide probe. 272 
Briefly, immediately after the 100kJ time trial, a 50 mL sugar probe solution (5 g lactulose, 2 g 273 
rhamnose) was consumed and the ratio of the sugars was measured from serum samples 60 minutes 274 
after ingestion. Concentrations of intestinal-fatty acid binding protein (I-FABP) were measured pre, 275 
post and 1 hour post exercise from EDTA plasma using an ELISA (Hycult Biotechnology, Uden, the 276 
Netherlands; detection window 47 - 5000 pg·mL-1) according to the manufacturer’s instructions. 277 
Specific GI symptoms were recorded every 30 min during exercise whereby a visual analogue scale 278 
was used to assess specific symptoms such as bloating, nausea, urge to vomit, urge to defecate were 279 
assessed. GI symptoms were scored on a 10-point scale (0 = no symptoms and 9 = very severe 280 
symptoms) with a score > 4 being regarded as moderate. To ensure understanding, specific symptoms 281 
were explained and described to participants. 282 
Statistical analysis 283 
ANOVA for repeated measures was used to compare differences in substrate utilization and in blood 284 
related parameters over time between the trials. A Tukey’s post hoc test was applied in the event of 285 





conducted by using a Student’s t-test for paired samples. For plasma metabolites, area under the curve 287 
(AUC) calculation was completed using and differences between conditions were compared using a 288 
Student’s t-test for paired samples. To detect a meaningful increase in exogenous CHO oxidation of 289 
0.1 g·min-1 with a standard deviation (SD) of 0.05 g·min-1 (58) at 80% power, a minimum of 5 290 
participants would be required. All values are expressed as means ± SD. Statistical significance was set 291 
at P < 0.05. 292 
Results 293 
Physiological response to exercise 294 
Participants cycled for 2 hours at 180 ± 20 W across trials corresponding to 55% of their Wmax.  There 295 
were no significant differences between mean heart rate (149 ± 18 vs 146 ± 16 b·min-1), V̇O2 (34.5 ± 296 
3.9 vs 34.2 ± 3.4 mL·kg-1·min-1), or RPE (12 ± 1 vs 12 ± 1) for PLC and PRO, respectively. CHO and fat 297 
oxidation during each hour are presented in Table 1. CHO oxidation was lower during the second hour 298 
in both trials. CHO oxidation was higher (P = 0.019) in the second hour in PRO compared to PLC. Fat 299 
oxidation was lower in PRO during both the first (P = 0.026) and the second (P = 0.004) hour compared 300 
to PLC. Energy expenditure did not differ between PLC (6292 ± 644 kJ) and PRO (6232 ± 493 kJ) (P = 301 
0.662).   302 
Substrate utilisation during 60 – 120 min exercise period  303 
Plasma [U-13C]glucose /12C glucose ratios increased as a result of maltodextrin/[U-13C]glucose drink 304 
and was stable during the 60-120 min period (Figure 1A). Baseline 13C-enrichments from resting breath 305 
samples were comparable between PLC (-25.2 ± 3.6 ‰ vs PDB) and PRO (-25.0 ± 1.8 ‰ vs PDB) (P > 306 
0.05). Changes in enrichment after ingestion of the drink at the start of 2 h of endurance exercise at 307 
55% Wmax are shown in Figure 1B. 13CO2 enrichments levelled off from 45 min during both trials and 308 
there were no significant differences at any time point between PLC and PRO. 309 
 310 
Mean CHO substrate oxidation during 60-120 min is summarised in Table 2. Mean oxidation of the 311 
ingested maltodextrin/[U-13C]glucose drink was higher in PRO compared to PLC (Table 2), as was the 312 
maximal oxidation observed (0.84 ± 0.10 vs 0.77 ± 0.09 g·min-1, P = 0.016) which was achieved at 120 313 
min during both trials (Fig S1). There was no difference in mean liver-derived glucose oxidation and 314 






Blood metabolites 317 
At the start of exercise, plasma glucose, lactate, NEFA and glycerol concentrations were all similar in 318 
both trials (Figure 2). Plasma glucose increased during the first 30 min of exercise before decreasing 319 
at 45 min and remained stable for the rest of the exercise bout. When expressed as AUC, there was a 320 
significant difference between PRO and PLC (P = 0.013) (Figure 2A). After the ingestion of the 321 
maltodextrin drink, there were significant and concomitant increases and decreases in exogenously 322 
derived and endogenous plasma glucose concentrations, respectively (P < 0.05) (Figure 3). Plasma 323 
glucose concentrations derived from exogenous glucose was significantly greater at 15 min in PRO 324 
compared to PLC (P = 0.01) (Figure 3A). Plasma lactate increased in response to exercise to ~2 mmol·L-325 
1 and then gradually declined during the course of the exercise bout (Figure 2B). Insulin concentrations 326 
were higher at 30, 45 and 75 min in PRO compared to PLC (P < 0.05) with a significant difference 327 
between AUC data (P = 0.04). NEFA concentrations reduced at the onset of exercise and subsequently 328 
increased from 60 min in both trials, with a significant difference between trials by 120 min (P = 0.043) 329 
(Figure 2D). Plasma glycerol increased during exercise in both trials, with significantly lower 330 
concentrations at 1200 min during PRO compared to PLC (P > 0.001) (Figure 2E).  331 
 332 
Markers of GI permeability, damage and cytokines 333 
Individual data points for LR during PRO and PLC are presented in Figure 4A. There was no significant 334 
difference in LR between PRO (0.045 ± 0.02) and PLC (0.052 ± 0.03) (P = 0.436). For I-FABP, there was 335 
no significant difference between PRO and PLC pre (P = 0.364), post (P = 0.374) or 1hr post exercise (P 336 
= 0.393) for PRO and PLC, while there was also no effect of exercise (Figure 3B). Plasma cytokine 337 
concentrations for pre and post-exercise are presented in Table 3. For pre-exercise measures, IL-1α 338 
and IL-6 concentrations were lower in PRO, while IL-6 was also lower post-exercise in PRO.  339 
 340 
GI symptoms and time trial performance 341 
During exercise trials, individual GI symptoms assessed were low (< 4 on scale of 0-10), even when 342 
using maximum values from each trial. During the 100kJ time trial there was no significant difference 343 
in the time to complete between placebo (308 ± 69 s) and probiotic (301 ± 74 s) (P = 0.714).  344 





Discussion  346 
The main aims of this study were to investigate the potential of 4 weeks of probiotics supplementation 347 
(PRO) compared to placebo (PLC) to alter exercise metabolism and improve performance in trained 348 
athletes during 2 h of cycling exercise at moderate intensities. One of our hypotheses was that PRO 349 
would exert this effect via positive effects on GI permeability and prevention of GI damage. This was 350 
difficult to ascertain given that there were no increases in exercise-induced damage/permeability, 351 
most likely relating to the exercise intensity. The other hypothesis was that PRO would increase the 352 
maximal rate of the oxidation of maltodextrins to a value higher than the maximal value of 1 g·min-1 353 
which we observed in a previous study (53). To the authors’ knowledge, this is the first study to 354 
investigate whether PRO, compared to PLC, has the potential to increase the oxidation rate of both 355 
total carbohydrates and orally ingested maltodextrins during endurance exercise. The use of stable 356 
isotope tracer methodologies, in combination with indirect calorimetry, has enabled us to quantitate 357 
total CHO and total fat oxidation and the gradual change in the fraction of plasma glucose originating 358 
from the ingestion of the maltodextrin drink and estimate muscle glycogen and liver glucose utilisation 359 
over the 120 min exercise period (Fig. 3).  360 
We have shown for the first time that PRO leads to a small but significant increase in total 361 
carbohydrate oxidation in the 60-120 min exercise period (Table 1) by increasing both the oxidation 362 
of the ingested maltodextrins (P=0.024) and muscle glycogen (NS) compared to placebo (Table 2). The 363 
increase in total CHO oxidation coincided with a decrease in total fat oxidation (Table 1). It is well-364 
established that the ingestion of multiple transporter carbohydrates (i.e. glucose and fructose) can 365 
improve the oxidation of exogenous CHO well above the values reported here (~1.5 g·min-1 vs 0.8-0.9 366 
g·min-1) (11, 25). However, the proof of principle shown here that PRO may alter substrate utilisation 367 
and increase the oxidation of glucose derived from ingested maltodextrins warrants further 368 
investigation to both replicate this finding and observe if this apparent difference is observed when 369 
both glucose and fructose are consumed during exercise. If the results here are replicated, this would 370 
at the very least be of interest to those exercising for 1-2.5 hrs, for which current CHO intake 371 
recommendations are 30-60 g per hour during exercise (5). 372 
We, in this and previous studies (53), have chosen to orally administer a 10% maltodextrin solution as 373 
maltodextrins are rapidly hydrolysed into free glucose and absorbed into the vena porta. The rapid 374 
hydrolysis of maltodextrins in the human GI tract is an important reason for their frequent use in 375 
commercial sports drinks (18). In the previous study (53) we have used maltodextrins naturally 376 
enriched with 13C. In the current study we have mixed the maltodextrin solution with a [U-13C]glucose 377 
tracer to thus achieve a high plasma glucose TTR. This was required in this study to facilitate accurate 378 





production and oxidation of glucose by the liver (sum of liver glycogen breakdown and 380 
gluconeogenesis).  Pilot data in the first two participants revealed that the plasma [U-13C]glucose 381 
enrichment reached a plateau in the 30-120 min period, therefore excluding a difference in 382 
appearance kinetics between the maltodextrin solution and the [U-13C]glucose tracer. The profile of 383 
the 13C-enrichment curves of the breath gas samples was similar to the profiles seen in a previous 384 
study in which we used naturally enriched maltodextrins (53). For breath gas samples, a plateau was 385 
reached towards the end of the second hour in both studies. However, the variation between 386 
individuals in plateau enrichment was lower here than with naturally enriched maltodextrin 387 
consumption (53). Such variations in plateau enrichments have been shown to be the consequence of 388 
variations in the natural 13C-enrichment of individuals’ endogenous carbohydrate stores (54). In the 389 
current study the [U-13C]glucose enrichment was >100-fold higher than seen in Wagenmakers, Brouns, 390 
Saris and Halliday (53), and the variation between the 7 participants for the plasma [U-13C]glucose TTR 391 
and breath 13CO2 enrichment ( per mil vs PDB) were minimal (Figure 1A and 1B). We believe that the 392 
current study is therefore the first to validate the use of a mixture of naturally enriched maltodextrins 393 
with a [U-13C]glucose tracer to estimate the oxidation of the maltodextrin solution during prolonged 394 
exercise. 395 
It is clear in the present study that there are small but significant differences in fuel selection between 396 
PRO and PLC. The AUC data for plasma glucose and plasma insulin concentrations were higher for PRO 397 
than for PLC (Fig 2), suggesting that the intestinal absorption of glucose, particularly in the first 30 min 398 
of exercise, was higher for PRO than for PLC. This is supported by the higher plasma glucose 399 
concentration originating from the ingested maltodextrins after 15 minutes of exercise during PRO 400 
compared to PLC (Figure 3A). Higher duodenal glucose absorption rates are known to stimulate insulin 401 
production by the pancreatic β-cells (40). Higher systemic insulin concentrations, as are seen during 402 
PRO compared to PLC (Fig 1C), have previously been shown to suppress lipolysis in subcutaneous 403 
adipose tissue (7). It has been shown that oral ingestion of glucose before and during exercise reduced 404 
lipolysis both in subcutaneous adipose tissue stores and lipolysis of the intramuscular triglyceride 405 
(IMTG) stores in skeletal muscle (10). This led to a substantial reduction in the oxidation rate of plasma 406 
FA, IMTG and total fat during exercise (10). These mechanisms contribute to the lower plasma NEFA 407 
and glycerol levels (Figure 2D and 2E) and the reduction in total fat oxidation in PRO compared to PLC 408 
(Table 1). However, the small difference in intestinal absorption suggested here does not likely fully 409 
explain the differences in plasma insulin and glycerol. Other GI related factors, such as the intestinal 410 
incretin response have been shown to effect insulin response to an oral glucose load (16). It may then 411 
be plausible that differences in other GI related factors that following PRO supplementation, explain 412 





During the 2 h of exercise there is a gradual increase in the fraction of plasma glucose originating from 414 
the oral ingestion of the maltodextrin drink (Fig 3A), while at the same time there is a reduction in the 415 
fraction of glucose produced by the liver (sum of liver glycogen breakdown and gluconeogenesis; Fig. 416 
3B). The plasma glucose concentration (sum of the 2 fractions) remains constant. These data 417 
collectively support the concept that the liver acts as a 'glucostat' (8, 38, 56). The data in Fig 3A-B and 418 
in previous work (10, 26) clearly show that oral ingestion of carbohydrates reduces endogenous 419 
glucose production in proportion to the intestinal absorption rate of glucose and oxidation rate of 420 
glucose in the exercising muscles. This role of the liver as a 'glucostat' keeping the blood glucose 421 
concentration during exercise constant explains the data we obtained in the current study.  422 
While we have presented data that demonstrates differences in exercise metabolism following PRO, 423 
we did not observe any difference in 100 kJ time trial performance between supplement groups. It 424 
was hypothesised that, had PRO resulted in greater consumed CHO absorption and oxidation had been 425 
substantially increased, this would have resulted in larger muscle and/or liver glycogen stores. This 426 
would then be of benefit during a higher intensity exercise performance test, following an initial 427 
endurance exercise, as has been seen previously with exogenous CHO feeding studies (17, 34). A time 428 
trial lasting ~240-360s was chosen as this has been shown to be a reliable performance indicator in 429 
trained cyclists (30) and suggested to be at the higher end of duration of sustained power output 430 
increases during successful breakaways during professional road cycling (1). The failure to observe an 431 
effect of PRO on performance is most likely related to the small increase in the oxidation of exogenous 432 
CHO during the preceding exercise. Greater increases in exogenous CHO oxidation following PRO 433 
would have likely reduced muscle and/or liver glycogen oxidation and thus spared for use during the 434 
higher intensity exercise during the time trial. However, it should also be highlighted that a limitation 435 
of the time trial performance measure here was the potential lack of statistical power. While the 436 
primary outcome, and thus power calculation performed to ensure sufficient sample size, was to 437 
detect differences in exercise metabolism, this may have been under powered for a number of 438 
secondary measures, including the time trial performance and GI measures.  439 
The presented GI permeability and damage data did not show an increase in measures for I-FABP or 440 
GI symptoms during 120 min of cycling, while GI permeability was not different between PRO and PLC 441 
and many values were similar to resting values previously reported in our laboratory (41, 42). GI 442 
permeability has previously been reported to only significantly increase compared to resting values at 443 
exercise intensity of ≥80% V̇O2max at ambient temperatures (37), while increases in plasma I-FABP have 444 
also not always been shown during moderate intensity exercise, particularly when subjects maintain 445 
euhydration and consume CHO (29). In the present trial, exercise intensity was 55% Wmax (~55V̇O2peak). 446 





intensities experienced by professional road cyclists during competition (36) and the intensity at which 448 
they are most likely to consume CHO during exercise.. In regards to GI symptoms, these were generally 449 
low, again most likely due the chosen exercise modality (cycling instead of running), duration, and 450 
intensity, which do not appear to have led to a sustained functional challenge to the GI system. To 451 
better investigate the effects of probiotics on exercise induced GI permeability, damage and 452 
symptoms, particularly in the presence of carbohydrate ingestion, exercise of a greater intensity and 453 
duration should be considered.  454 
We conclude that the presented stable isotope tracer data demonstrate for the first time in humans 455 
in vivo that after 4 weeks of PRO during 2 h of cycling exercise at 55% Wmax a small, but significant 456 
increase in the oxidation rate of glucose originating from an orally ingested maltodextrin solution was 457 
observed. We also show significant increases in the plasma glucose and insulin concentration with 458 
significant increases occurring in the 2 h area under the curve (AUC) both for plasma glucose and 459 
plasma insulin (Fig 2) following PRO. The higher plasma insulin concentrations during exercise reduce 460 
total fat oxidation (Table 2) via inhibition of lipolysis of subcutaneous adipose tissue and IMTG lipolysis 461 
as we have shown previously (10). Although these data show that PRO does lead to small, but 462 
measurable changes in fuel selection and oxidation during exercise, they do not confirm our prior 463 
hypothesis that PRO could lead to larger increases in the absorption and oxidation rate of the ingested 464 
maltodextrins or increases the maximal maltodextrin oxidation rates reached a plateau to values 465 
higher than 1 g·min-1.  466 
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 Table 1. CHO and fat metabolism during 0-60 and 60-120 min. Data are mean ± SD. *Significantly different from PLC (P < 641 
0.05) 642 
 643 
  644 
 0-60 min 60-120 min 
 PLC PRO P 
value 
PLC PRO P 
value 
RER 0.89 ± 0.03 0.92 ± 0.03* 0.037 0.86 ± 0.03 0.90 ± 0.02* 0.005 
CHO oxidation (g·min-1) 2.11 ± 0.45 2.38 ± 0.32 0.087 1.87 ± 0.39 2.20 ± 0.25* 0.038 





Table 2. Mean CHO utilisation calculated during 60-120 min. Data are presented as g.min-1 and are mean ± SD. *Significantly 645 




  650 
 PLC PRO P-value 
Ingested maltodextrin 0.75 ± 0.09 0.79 ± 0.10* 0.024 
Liver-derived glucose 0.21 ± 0.08 0.19 ± 0.04 0.323 





Table 3. Pre and post-exercise cytokine concentrations for PLC and PRO. Data are mean ± SD. 651 
 Pre-exercise 120 min 
 PLC PRO P value PLC PRO P value 
IL-1α (pg·mL-1) 1.39 ± 0.82 0.63 ± 0.64 0.031* 1.84 ± 1.23 1.78 ± 1.40 0.450 
IL-6 (pg·mL-1) 2.32 ± 1.22 1.22 ± 0.90 0.037* 3.69 ± 2.02 2.27 ± 1.19 0.049* 
IL-8 (pg·mL-1) 2.49 ± 1.18 2.53 ± 1.38 0.481 4.70 ± 1.57 4.49 ± 2.83 0.409 
IL-10 (pg·mL-1) 1.95 ± 1.37 1.14 ± 0.90 0.093 3.13 ± 2.05 3.25 ± 3.09 0.433 
 652 





Figure 1. (A) Plasma glucose tracer/tracee ratio (TTR) and (B) Breath 13CO2 enrichment during exercise. Values are means ± 654 
SD. PDB, Pee Dee Belemnite 655 
 656 
 657 
Figure 2. Plasma (A) glucose, (B) lactate, (C) insulin, (D) NEFA, and (E) glycerol. *significant difference between PRO and PLC 658 
at the corresponding time point (P<0.05). # significant difference between PRO and PLC 659 
 660 
Figure 3. Plasma glucose concentration derived from (A) glucose derived from ingested maltodextrin, (B) endogenously-661 
derived glucose sources *significant difference between PRO and PLC at the corresponding time point (P<0.05).  662 
 663 
 664 
Figure 4. A) Serum lactulose:rhamnose ratio for PRO and PLC. B) Intestinal-fatty acid binding protein (I-FABP) pre, post and 665 
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